Figure 1.
Outcome of the treatment chlorambucil-obinutuzumab. (A) PFS, TTNT, and OS curves of the entire cohort. (B) PFS, TTNT, and OS curves by change in dose of chlorambucil. (C) PFS, TTNT, and OS curves by obinutuzumab RDI reduction >20%.
Outcome of the treatment chlorambucil-obinutuzumab. (A) PFS, TTNT, and OS curves of the entire cohort. (B) PFS, TTNT, and OS curves by change in dose of chlorambucil. (C) PFS, TTNT, and OS curves by obinutuzumab RDI reduction >20%.